NASDAQ:SGRY Surgery Partners (SGRY) Stock Price, News & Analysis $14.26 -0.29 (-1.97%) As of 01:27 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Surgery Partners Stock (NASDAQ:SGRY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Surgery Partners alerts:Sign Up Key Stats Today's Range$14.09▼$14.6250-Day Range$13.23▼$15.9552-Week Range$11.41▼$23.44Volume484,906 shsAverage Volume1.71 million shsMarket Capitalization$1.87 billionP/E RatioN/ADividend YieldN/APrice Target$19.00Consensus RatingModerate Buy Company Overview Surgery Partners, Inc. (NASDAQ:SGRY) is a healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals in partnership with physicians and health systems. Its facilities provide scheduled surgical care in outpatient and inpatient settings, with an emphasis on procedures that generally do not require extended hospital stays. The company supports a range of specialties, including orthopedics, pain management, ophthalmology, gastroenterology, gynecology, and general surgery. Its services may include facility operations, clinical support, revenue-cycle management, and other administrative functions designed to help physician partners deliver surgical care. Surgery Partners serves patients through a network of facilities across the United States. Founded in 2004, the company has expanded through the development, acquisition, and operation of surgical facilities and physician partnerships. Its business model is focused on providing cost-effective alternatives to traditional hospital-based surgery while maintaining access to specialized care.AI Generated. May Contain Errors. Read More Surgery Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks70th Percentile Overall ScoreSGRY MarketRank™: 3.49921114909 of 5 starsSurgery Partners scored higher than 70% of companies evaluated by MarketBeat, and ranked 220th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingSurgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on no strong buy ratings, 7 buy ratings, 3 hold ratings, and 1 sell rating.Upside PotentialSurgery Partners has a consensus price target of $19.00, representing about 32.0% upside from its current price of $14.40.Amount of Analyst CoverageSurgery Partners has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Surgery Partners' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth4.00% Earnings GrowthEarnings for Surgery Partners are expected to grow by 4.00% in the coming year, from $0.25 to $0.26 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -20.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -20.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioSurgery Partners has a PEG Ratio of 4.41. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Surgery Partners' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.18% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 5.35.Change versus previous monthShort interest in Surgery Partners has recently increased by 7.98%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.62 News SentimentSurgery Partners has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Surgery Partners this week, compared to 3 articles on an average week.Search Interest2 people have searched for SGRY on MarketBeat in the last 30 days. Company Ownership2.2 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $143,500.00 in company stock, which represents 0.0076% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $143,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders2.00% of the stock of Surgery Partners is held by insiders.Percentage Held by InstitutionsSurgery Partners has minimal institutional ownership at this time.Read more about Surgery Partners' insider trading history. Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGRY Stock News HeadlinesSurgery Partners (NASDAQ:SGRY) Stock Price Breaks Below 50-Day Moving Average - Here's WhyOctober 13 at 3:03 AM | americanbankingnews.comSurgery Partners (SGRY) Faces Softer Volumes With Fair Value Still HigherOctober 10, 2026 | finance.yahoo.comTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower prices before November 3. One small oil and gas company sits atop the largest oil and gas deposit ever found on American soil and is integrating AI technology into its wells, with margins rivaling firms valued ten times higher. A previous stock pick from this same screening process rose more than 1,000 percent in under 12 months.October 14 at 1:00 AM | Monument Traders Alliance (Ad)Is Surgery Partners (SGRY) Cheap After a 65% Five Year Fall?October 9, 2026 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC), Immix Biopharma (IMMX) and Surgery Partners (SGRY)October 1, 2026 | theglobeandmail.comSurgery Partners' Idaho Falls Sales Tightens Core Strategy, RBC SaysSeptember 30, 2026 | marketscreener.comMSurgery Partners (SGRY): Buy, sell, or hold post Q2 earnings?September 23, 2026 | msn.comSurgery Partners closes $800 million deal for Idaho hospitalsSeptember 22, 2026 | bizjournals.comSee More Headlines SGRY Stock Analysis - Frequently Asked Questions How have SGRY shares performed this year? Surgery Partners' stock was trading at $15.45 at the beginning of the year. Since then, SGRY stock has decreased by 6.8% and is now trading at $14.3950. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings results on Monday, August, 10th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners's quarterly revenue was up 2.7% on a year-over-year basis. Read the conference call transcript. Is Surgery Partners doing a stock buyback? Surgery Partners' board approved a share repurchase program on Thursday, February 26th 2026, which permits the company to buy back $200,000,000 in shares, according to EventVestor. This means that the company could buy up to 9.7% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its shares are undervalued. When did Surgery Partners IPO? Surgery Partners (SGRY) raised $350 million in an IPO on Thursday, October 1st 2015. The company issued 14,285,000 shares at a price of $23.00-$26.00 per share. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Tesla (TSLA), Bristol Myers Squibb (BMY), Enterprise Products Partners (EPD), GE Aerospace (GE) and Energy Transfer (ET). Company Calendar Last Earnings8/10/2026Today10/14/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 As of 5 days ago, SGRY's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Facilities Current SymbolNASDAQ:SGRY CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees16,000Year Founded2004Price Target and Rating Average Price Target for Surgery Partners$19.00 High Price Target$30.00 Low Price Target$14.00 Potential Upside/Downside+33.7%Consensus RatingModerate Buy Rating Score (0-4)2.55 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)($0.70) Trailing P/E RatioN/A Forward P/E Ratio56.86 P/E Growth4.41Net Income-$77.90 million Net Margins-2.63% Pretax Margin3.04% Return on Equity0.88% Return on Assets0.34% Debt Debt-to-Equity Ratio1.18 Current Ratio1.95 Quick Ratio1.78 Sales & Book Value Annual Sales$3.31 billion Price / Sales0.56 Cash Flow$1.70 per share Price / Cash Flow8.34 Book Value$24.21 per share Price / Book0.59Miscellaneous Outstanding Shares130,920,000Free Float128,300,000Market Cap$1.86 billion OptionableOptionable Beta1.90 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:SGRY) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredMy next big call (under $1)The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a...Crypto 101 Media | SponsoredElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men d...Paradigm Press | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
